The Arab Drug Company (EGX:ADCI)

The Arab Drug Company Ratios and Metrics

Market cap in millions EGP. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 1, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	2,042	482	401	275	397	354
Market Cap Growth	271.95%	20.27%	45.83%	-30.70%	12.18%	98.95%
Enterprise Value	2,471	766	505	302	355	305
Last Close Price	170.13	37.31	28.90	18.02	23.73	19.79
PE Ratio	12.86	5.46	5.64	3.61	3.91	3.81
Forward PE	-	8.58	8.58	8.58	8.58	8.58
PS Ratio	1.99	0.61	0.63	0.55	0.74	0.68
PB Ratio	3.64	1.05	1.05	0.81	1.28	1.42
P/TBV Ratio	3.64	1.05	1.05	0.81	1.28	1.42
P/FCF Ratio	74.57	-	16.49	-	51.48	5.00
P/OCF Ratio	13.15	3.55	4.58	8.37	10.85	4.83
EV/Sales Ratio	2.41	0.98	0.80	0.60	0.66	0.59
EV/EBITDA Ratio	8.90	5.98	5.08	3.01	2.73	2.59
EV/EBIT Ratio	9.85	6.48	5.21	3.32	2.90	2.60
EV/FCF Ratio	90.25	-	20.77	-	46.03	4.32
Debt / Equity Ratio	0.95	1.13	0.50	0.44	0.07	0.06
Debt / EBITDA Ratio	1.91	4.01	1.91	1.51	0.16	0.12
Debt / FCF Ratio	19.33	-	7.90	-	2.75	0.20
Asset Turnover	0.87	0.87	1.01	0.99	1.31	1.55
Inventory Turnover	2.21	2.12	1.71	1.61	1.85	2.08
Quick Ratio	0.72	1.01	0.73	0.68	0.80	0.76
Current Ratio	1.51	1.93	2.49	2.31	2.75	2.64
Return on Equity (ROE)	36.91%	24.43%	22.88%	23.48%	36.32%	42.35%
Return on Assets (ROA)	13.26%	8.13%	9.66%	11.12%	18.67%	21.87%
Return on Capital (ROIC)	15.25%	9.52%	11.38%	13.80%	25.73%	31.14%
Return on Capital Employed (ROCE)	30.50%	15.00%	19.80%	23.10%	39.50%	47.10%
Earnings Yield	7.78%	21.32%	20.64%	27.74%	25.55%	26.23%
FCF Yield	1.34%	-17.24%	6.07%	-20.74%	1.94%	19.98%
Dividend Yield	2.45%	11.19%	7.79%	13.32%	10.54%	6.32%
Payout Ratio	32.23%	35.11%	45.29%	57.06%	38.31%	34.69%
Buyback Yield / Dilution	-12.16%	-	11.45%	2.11%	6.76%	6.65%
Total Shareholder Return	-9.71%	11.19%	19.24%	15.43%	17.29%	12.96%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.